INTRODUCTION
One way to improve the success in obtaining pure membrane proteins for biochemical and structural analysis is to use GFP-based fusion technology. As the C-terminal GFP folds and becomes fluorescent only if the upstream membrane protein integrates into the membrane, the resultant fluorescence is a fast and accurate measure of membrane-integrated expression 1 . Fluorescence is easy to measure directly in liquid culture, standard SDS-gels and detergent-solubilized membranes 2, 3 . Detergent-solubilized membranes can also be subjected to fluorescence size-exclusion chromatography (FSEC) to measure the 'monodispersity' of the sample 4 . FSEC was recently used to facilitate the purification of the chicken acid-sensing ion channel which crystallized and diffracted to 1.9-Å resolution 5 . In short, although membrane-integrated expression is no guarantee of function, the GFP-tag, nevertheless, speeds up the empirical process that all membrane proteins are required to go through on the way to obtain stable and homogeneous material for functional and structural work.
On the basis of a recent publication 6 , we have constructed a reliable protocol for screening the overexpression and purification of eukaryotic membrane proteins in Saccharomyces cerevisiae. This system was adapted from a GFP-based Escherichia coli pipeline 2 , because yeast possess salient features absent in E. coli that are often essential for producing functional eukaryotic membrane proteins (e.g., post-translational modification and a more suitable lipid composition). With the exception of the human lipoxygenase structure to 4-Å resolution 7 , these differences could explain why functional eukaryotic membrane proteins in E. coli have failed to give high-resolution structures. With similar costs to E. coli and the possibility to clone by homologous recombination into standard vectors, S. cerevisiae is a convenient and efficient expression host to use. Although more structures of eukaryotic membrane proteins have been determined using material isolated from heterologous overexpression in the methylotrophic yeast Pichia pastoris, this difference is likely due to the popularity of P. pastoris because of its ability to produce a large biomass during fermentation with methanol 8 . However, recent work has demonstrated that S. cerevisiae is also a suitable host for obtaining enough material that will give high-resolution membrane protein structures 9, 10 .
Using GFP-fusions, we can quickly identify membrane proteins that are highly overexpressed in S. cerevisiae. From our analysis of B150 eukaryotic membrane protein-GFP fusions, approximately one-quarter can be overexpressed to 41 mg l À1 . The reason we prefer to screen in S. cerevisiae, rather than P. pastoris, is that cloning in P. pastoris is more time-consuming, as genes must be cloned into vectors, typically in E. coli, before their genomic integration. S. cerevisiae also has the added advantage that numerous localization studies have been carried out with functional GFPfusions, and because S. cerevisiae has a highly regulated and extensively characterized quality-control system in the endoplasmic reticulum 11, 12 , assessing localization of fusions under overexpression conditions can be used as a good indication of functional expression. Of the highly expressed eukaryotic membrane proteins in S. cerevisiae, we find that more than half of those tested are targeted to the correct organelle and are monodisperse in more than one detergent 6 . Many eukaryotic membrane proteins have been purified to high levels (45 mg from 10 l) in our laboratory, and for those tested, functional data (Sonoda, Y. et al., manuscript in preparation) are consistent with other studies 13 . However, we also anticipate that, due to an absence of certain lipids (e.g., cholesterol), membrane proteins that express well in yeast may in some cases need to be produced in insect or mammalian cells for structural work. Nonetheless, because of its speed and comparatively low cost, S. cerevisiae remains a valuable prescreening host even in such situations.
Here, we describe in detail the practical steps that constitute our S. cerevisiae GFP-based pipeline. This comprises (i) cloning by homologous recombination, (ii) whole-cell and in-gel fluorescence for estimating expression, (iii) confocal microscopy for confirming subcellular localization, (iv) FSEC for selecting detergents for purification, (v) GFP fluorescence-assisted immobilized metal-affinity chromatography (IMAC) and (vi) removal of GFP by His-tagged tobacco etch virus (TEV) protease and reverse IMAC (Fig. 1) .
MATERIALS

REAGENTS
. pep4 Deletion yeast strain, for example, FGY217 (MATa, ura3-52, lys2D201, pep4D) 14 . N,N-Dimethyldodecylamine N-oxide (LDAO; Anatrace, cat. no. D360) . n-Decyl-b-D-maltopyranoside (DM; Anatrace, cat. no. D322) . n-Dodecyl-b-D-maltopyranoside (DDM; Anatrace, cat. no. D310) . Fos-choline 12 (Anatrace, cat. no. F308) . Polyethylene(9)dodecyl ether (C12E9; Anatrace, cat. no. AP0129) . Pure yeast-enhanced green fluorescent protein (yEGFP) (S65G; S72A) 15 . Cholesterol REAGENT SETUP) . DMSO (Sigma, cat. no. D2438) . Novex 12% Tris-Gly gels (Invitrogen) . -URA media (see REAGENT SETUP) . Yeast suspension buffer (YSB) (see REAGENT SETUP) . PBS (see REAGENT SETUP) . Solubilization buffer (SB) for in-gel fluorescence (see REAGENT SETUP) . Cell resuspension buffer (see REAGENT SETUP) . Equilibration buffer (EB) (see REAGENT SETUP) . Membrane resuspension buffer (MRB) (see REAGENT SETUP) . Dialysis buffer (DB) (see REAGENT SETUP)
EQUIPMENT
. Ä kta FPLC system (GE Healthcare) . Frac-950 fraction collector with Rack C (GE Healthcare) . Peristaltic pump P-1 (GE Healthcare) . 5-ml His-trap columns (GE Healthcare) . Constant Systems TS series cell disruptor (Constant Systems) . Dialysis tubing, 12-14 kDa molecular weight cut-off (Spectrumlabs) . LAS-1000-3000 charge-coupled device (CCD) imaging system (Fujifilm) . Nunc 96-well black optical bottom plate (Nunc) . Poly-Prep/glass Econo-Column chromatography columns (Bio-Rad) . Shaking incubator with temperature control (New Brunswick Scientific) . SpectraMax M2e microplate reader (Molecular Devices)
. Superose 6 10/300 GL Tricorn gel filtration column (GE Healthcare) . Superdex 200 10/300 GL Tricorn gel filtration column (GE Healthcare) . Acid washed glass beads, 500 mm (Sigma) . Universal laboratory mixer-mill disruptor, for example the TissueLyser mixer (Qiagen) . 50-ml Aerated capped tubes (TPP) . Tunair 2.5-l full baffled shaker flasks (VWR) . Preparative ultracentrifuge, Beckman Coulter Optima L-XP series with Beckman 45Ti rotor (Beckman) . Benchtop 15 (less start Methionine) with a C-terminal octa-His tag and a TEV protease site upstream of GFP-8His into a 2 m vector that harbors a GAL1 promoter and URA selection marker (p424GAL1) 17 . In addition, introduce a SmaI site preceding the TEVp-GFP-8His sequence (Fig. 2a) . Digestion of vector with SmaI gives rise to blunt ends that eliminate background colonies (typically o5) caused by the re-annealing of linearized vector during transformation by homologous recombination (problem when restriction enzymes that produce sticky ends are used). Note that although we recommend a GAL1 promoter, in some cases, a constitutive promoter gives higher expression. For propagation of yeast vector, use E. coli with appropriate antibiotic. As there are examples where an N-terminal GFP-fusion is more suitable for functional 18 or structural work 5 than a C-terminal GFP fusion, an N-terminal GFP fusion vector should also be considered. Note, however, that an N-terminal GFP fusion may reduce expression for N out -membrane protein topologies 19 , and as the upstream GFP can be translated more efficiently than the downstream membrane protein, the GFP fluorescence from whole cells is no longer a reliable reporter of membrane-integrated expression.
Cloning of membrane protein gene(s) into GFP-8His-containing vector by homologous recombination TIMING 5 d 2| Amplify the gene of interest with primers that include 5¢ overhangs (35 bp) complementing the upstream and downstream sequences to either side of the SmaI site in the GFP-8His vector (Fig. 2b) . m CRITICAL STEP Because we find that only a quarter of mammalian membrane proteins are heterologously overexpressed to 1 mg l À1 (see ANTICIPATED RESULTS), initial screening of at least 20 targets is recommended in order to implement this screening protocol effectively.
3| Transform with 5 ml of PCR product and 3 ml of SmaI-linearized vector solution into S. cerevisiae competent cells as described in Box 1. Typical number of colonies is B80-150. We recommend using a S. cerevisiae strain with the vacuolar pep4 deletion 6 . Check that the genotype of the yeast strain is compatible with the selection marker used in the vector. ' PAUSE POINT Yeast plates stored at 4 1C can be kept for 1 month with no reduction in the level of overexpression.
Screening membrane protein overexpression using whole-cell and in-gel fluorescence TIMING 4 d
4| Inoculate a colony of the yeast transformant in an aerated 50-ml tube containing 10 ml ÀURA medium with 2% glucose. m CRITICAL STEP Aeration-capped tubes should be used, as they produce a more reliable large-scale culturing estimate than nonaerated tubes.
5| Incubate the culture overnight in an orbital shaker at 280 r.p.m. set at 30 1C.
6| Spot 10 ml of each overnight culture onto a fresh ÀURA plate, allow to dry at room temperature and transfer to a 30 1C incubator for 1-2 d.
7|
Dilute the overnight culture (from Step 5) to an OD 600 of 0.12 into two 50-ml aerated tubes, each containing 10 ml ÀURA medium with 0.1% glucose. m CRITICAL STEP Make sure that 0.1% glucose is used and not 2% glucose in the expression media because high levels of glucose repress the GAL1 promoter, while the former helps to maintain cell growth. 8| Incubate the cultures from Step 7 in an orbital shaker at 280 r.p.m. set at 30 1C. At an OD 600 of 0.6 (after B7 h), induce expression of membrane protein-GFP fusion by adding 20% (wt/vol) galactose (final 2%). m CRITICAL STEP In order to avoid diluting culture medium, prepare the 20% galactose stock in ÀURA medium. Induction before reaching an OD 600 of 0.6 (typically) causes a reduced biomass that lowers protein production. Although the whole-cell GFP fluorescence can be higher if the cells are induced at a later OD 600 than 0.6, we find that there is proportionately greater degradation, so that there is no linear gain in the amount of membrane-integrated material produced (as measured in Step 32).
9| Twenty-two hours after induction, centrifuge the cells at 3,000g for 5 min, remove the supernatant and resuspend the cell pellet in 200 ml of YSB. m CRITICAL STEP It is important to culture for 22 h after galactose addition, as, although OD 600 is constant after 12 h, membrane protein production is maximal at 12-20 h after induction 6 . Because different final volumes can affect the level of whole-cell fluorescence measured, it is important to remove all of the supernatant. We recommend removal of supernatant by vacuum suction, or if it is removed by hand, to pat dry the tubes using absorbent paper.
10| Transfer 200 ml of the cell suspension to a black Nunc 96-well optical bottom plate. m CRITICAL STEP Because yeast cells settle to the bottom of the plate, for accurate measurements, proceed to Step 11 within 5 min of transfer.
11| Measure GFP fluorescence emission at 512 nm by excitation at 488 nm in a microplate spectrofluorometer. For plate readers with bottom read option, choose this setting. Estimate membrane protein overexpression levels (in mg l À1 ) from the yeast whole-cell fluorescence by applying the methodology detailed in Box 2 ( Table 1) . As previously illustrated, E. coli and S. cerevisiae whole-cell GFP fluorescent measurements (from samples with differing final OD 600 densities) correlate linearly (R 2 4 0.9) to expression levels as measured by the quantification of in-gel fluorescent band intensities 2, 6 .
12| Transfer the cell suspension from the 96-well plate into a 1.5-ml capped tube.
' PAUSE POINT The cell pellets can be stored at À20 1C for several days.
13| Add glass beads so that the final volume with the cell suspension is 500 ml. Add an additional 500 ml of YSB. Note that yeast cells are not solubilized directly by SB and need to be broken by other means for SDS-PAGE analysis.
14| Break the yeast cells with a mixer-mill disruptor set at 30 Hz for 7 min at 4 1C Alternatively, a vortex can be used, but we recommend using a heavy-duty lyser, as the cell breakage is more efficient, reproducible and easier to scale up.
15|
Remove unbroken cells by centrifugation at 22,000g in a desktop centrifuge for 5 s at 4 1C. Transfer 500 ml of the supernatant into a new tube. Add 500 ml of YSB to the mixture of unbroken cell pellet and glass beads. Repeat Step 14 and transfer the supernatant to the 500-ml batch obtained from the first round of cell breakage. 
BOX 2 | ESTIMATE OF MEMBRANE PROTEIN OVEREXPRESSION LEVELS
Membrane protein overexpression estimates from whole cells 1. Harvest 10 ml of yeast cells that have been cultured with and without galactose addition (to estimate background fluorescence), remove supernatant and resuspend in 200 ml of yeast suspension buffer (small-scale culture) or cell resuspension buffer (CRB) (from large-scale culture). 2. Measure GFP fluorescence as outlined in Steps 9-11 of the main procedure. For example, no addition of galactose addition (MP-GFP -GAL) ¼ 3,000 relative fluorescence units (RFU). Addition of galactose (e.g., Rattus norvegicus sugar transporter, Table 1 ) (MP-GFP + GAL) ¼ 31,291 RFU. 3. To correlate the whole-cell fluorescence with the amount of GFP produced, measure the fluorescence of a set concentration of yeast-enhanced green fluorescent protein (yEGFP) (in a final volume of 200 ml). For example, fluorescence of pure yEGFP at a concentration (conc.) of 0.03 mg ml À1 is 11,300 RFU. Drew et al. 2 have described the purification of GFP previously. Numerical estimate of whole-cell overexpression 4. Calculate GFP concentration in mg ml À1 in whole cells as follows:
ðMP À GFP + GALÞ À ðMP À GFP À GALÞ ðyEGFPÞ Â ðconc: yEGFPÞ ¼ Conc: GFP:
For example using the above measurements:
ð31;291 RFU À 3;000 RFUÞ ð11;300 RFUÞ Â ð0:03 mg ml À1 Þ ¼ 0:075 mg ml À1 of GFP:
5. To determine the concentration of GFP in 200 ml of cell culture, divide by 40 [8,000 ml (cell culture)/200 ml (resuspension volume)]. Although the initial cell culture volume was 10 ml, there is an effective 2-ml loss by the transfer of only 200 ml of the resuspended cells (200 ml buffer + cell pellet ¼ 250 ml) to the 96-well plate. 6. Using above example: (0.075 mg ml À1 )/40 ¼ 0.0018 mg ml À1 , which equates to an expression yield of 1.8 mg l À1 (upscale correlation between 10 ml screening volume versus 1 l is reliable 6 ). 7. As the typical recovery of GFP counts from 1-l culture into membranes is 60% (Fig. 3c,d 16| To pellet crude membranes, centrifuge the 1 ml of supernatant at 20,000g in a desktop centrifuge at 4 1C for 1 h. Alternatively, to collect membranes, the supernatant can be pelleted using a desktop ultracentrifuge (120,000g) for 1 h. However, we find the recovery from centrifugation in a desktop centrifuge is sufficient for this analysis, and as the final pellet is less compact, it is easier to resuspend (Step 17).
17| Resuspend crude membranes in 50 ml of YSB, and transfer 15 ml into a tube containing 15 ml of SB. Note: GFP fluorescence (in our instrument setup) does not linearly increase with the volume in the 96-well plate; that is, 100 ml of pure GFP (0.03 mg ml À1 ) ¼ 8,000 RFU and 200 ml of pure GFP (0.03 mg ml À1 ) ¼ 11,300 RFU. For this reason, it is important to use the same volume of GFP standard as the experimental sample volume in the 96-well plate. are clearly visible (Fig. 3, panel a) . m CRITICAL STEP Blue light is recommended over UV light, as it is closer to the excitation wavelength of GFP. In addition, we do not recommend detecting GFP-fusion expression by western-blotting, as the transfer of membrane protein-GFP fusions is often inconsistent between membrane protein samples. ? TROUBLESHOOTING
BOX 2 | CONTINUED
19|
Stain the SDS gel with Coomassie, and after sufficient time, transfer to destain. Note the intensity of Coomassie staining is a poor indication as to the levels of overexpression, as some membrane proteins bind Coomassie better than others 6 .
Optimization of membrane protein overexpression TIMING 3 d
20| Select the fusions that give the best overexpression as established in Steps 4-19. Using the spotted yeast culture (Step 6), inoculate 10 ml of ÀURA medium containing 2% glucose in aerated capped 50-ml tubes. Incubate the culture overnight in an orbital shaker set at 30 1C at 280 r.p.m.
21| Dilute the overnight culture to an OD 600 of 0.12 into six 50-ml aerated tubes containing 10 ml ÀURA medium with 0.1% glucose. Label two tubes each with the following: no chaperone addition, DMSO, His. Incubate at 30 1C at 280 r.p.m.
22|
Monitor the OD 600 of the cultures. Upon reaching an OD 600 of 0.6 (after B7 h), induce with 20% (wt/vol) galactose (final 2%). Add DMSO to a final concentration of 2.5% (vol/vol) and His to final concentration of 0.04% (wt/vol) to the tubes with the relevant labels (see Step 21) . Note that, for the initial optimization, we recommend adding either DMSO or His, as we find that the presence of these chemical chaperones can afford an additional 30% improvement to the whole-cell expression levels 6 . Until now it was unclear as to why these chemical chaperones can improve membrane protein production levels 20 .
23| Harvest cells after 22 h of induction and measure whole-cell GFP fluorescence as outlined in Steps 9-11. Using Steps 20-23, one can also test other culture conditions that have shown to be successful to improve membrane protein production, for example, the addition of a ligand to the culture medium 20 , or to switch the culture to 20 1C after galactose induction. However, in the latter case, we have found that only 5% of the targets we have tested give an additional improvement in expression compared with standard growth at 30 1C (ref. 6).
Confocal microscopy TIMING 2 d
24| Repeat the membrane protein overexpression culturing condition that gave the highest level of whole-cell fluorescence (Steps [20] [21] [22] . Resuspend harvested cells in 1 ml of ÀURA media containing 50% glycerol. Glycerol slows yeast mobility to facilitate the capture of quality images.
25| Add 1 ml of cell suspension to a microscope slide and place coverslip on top. Focus on the sample using Köhler illumination with a Â10 magnification lens. Set the focal plane to zero. m CRITICAL STEP Before setting any additional parameters on the microscope, make sure that you can see your cells in transmitted light. This is achieved through Köhler illumination, resulting in an even illumination of the sample with minimal flare. At this point, you can see whether your cells are granular, which can help interpret fusion localization, for example, punctuated internal spots are often seen as fluorescent vacuoles in Step 26.
26| Add a drop of lens oil, and change to the higher magnification oil-immersion lens. Turn off the brightfield lamp. Turn the blue light on, and estimate gross localization of the membrane protein-GFP fusion. Turn the blue light off. Use the argon laser and excite at 488 nm to capture a detailed localization image of the GFP-fusion (emission detection at 505-535 nm) (Fig. 4) . Note that in contrast to E. coli, in which GFP is inactively fused to periplasmic segments of inner-membrane proteins 21 (Fig. 3b) .
29| Harvest the cells after 22 h of incubation by centrifugation at 4,000g at 4 1C for 10 min. Decant the supernatant and resuspend the cell pellet in 25 ml of CRB per liter of original cell culture. m CRITICAL STEP From this step onward, even when not indicated, material should be kept on ice or at 4 1C. ' PAUSE POINT Cell suspensions can be rapidly frozen in liquid nitrogen and stored at À80 1C for up to 6 months. Use screw-capped tubes for storage.
30| Break the cells using heavy-duty cell disruptor for four passes at incremental pressures of 25, 30, 32 and 35 kpsi (B1.7-2.4 Â 10 3 atm) at 4-15 1C. Remove 100 ml of cells, transfer into a 96-well plate and measure GFP fluorescence as outlined in Step 11. m CRITICAL STEP It is advisable not to break the cells immediately at the higher pressure, as the suspension is more viscous at this stage and leads (often) to a blocked inlet valve. We recommend cell disruption using disruptors from Constant Systems, which typically break 75% of the yeast cells (as measured by GFP fluorescence). On the other hand, glass beads with a BeadBeater can be used to break yeast cells, but typically with lower efficiency with large culture volumes.
31|
Remove the unbroken cells and debris by centrifugation at 10,000g at 4 1C for 10 min and collect the supernatant containing membranes. Transfer 100 ml of supernatant to a 96-well plate and measure GFP fluorescence as outlined in Step 11. Calculate the yeast cell breakage efficiency by comparing GFP fluorescence to that measured in Step 30. ? TROUBLESHOOTING 32| To collect the membranes, centrifuge the cleared supernatant at 150,000g at 4 1C for 120 min. Discard the supernatant and resuspend the pellet to a final volume of 6 ml l À1 of original cell culture with MRB using a disposable 10-ml syringe with a 21-gauge needle. Transfer 100 ml of the membrane suspension into a 96-well plate and measure GFP fluorescence as outlined in Step 11. Calculate the amount of overexpressed membrane protein (Box 2). Calculate the amount of total protein using the BCA protein assay kit following the manufacturer's instructions. If the membranes isolated from 1 l of cells are resuspended in 6 ml of MRB, the GFP fluorescent counts typically match the original whole-cell fluorescent counts (Fig. 3c) . This corresponds to B60% of the amount of GFP measured in whole cells actually recovered into membranes (Fig. 3d) . Analysis of the supernatant from the high-speed spin, shown here for a typical membrane protein, indicates that B12% of the GFP-fusion is not pelleted (Fig. 3e) . Given cell-breakage efficiency of B75% means that the average fraction of 'free GFP' is B15%. ' PAUSE POINT Membrane suspensions can be rapidly frozen in liquid nitrogen and stored at À80 1C for up to 6 months. Although this is the routine in our laboratory, some membrane protein crystallographers avoid freezing and storing membranes and continue with purification immediately.
Detergent screen TIMING 2 h
33| Adjust the membrane suspension to a protein concentration of 3.5 mg ml À1 in PBS. Transfer 900 ml aliquots of the membrane suspension into 1.5-ml Beckman polyallomer microcentrifuge tubes.
34| Add 100 ml of each freshly prepared detergent listed in the table below (final 1%) to each of the 1.5-ml tubes containing 900 ml of membrane suspension (final 3 mg ml À1 ).
Incubate the mixtures at 4 1C for 1 h with mild agitation. We also recommend testing the addition of CHS to the detergent mixture (final 0.2%), as this can be essential for the isolation of monodisperse mammalian membrane proteins (Fig. 5a ). m CRITICAL STEP Other detergents should be screened. This selection is considered a starting point only. 35| Transfer 100 ml of the detergent-solubilized membranes into a 96-well plate and measure GFP fluorescence as outlined in
Step 11. To pellet nonsolubilized material, centrifuge the remaining 900 ml in a benchtop ultracentrifuge at 100,000g at 4 1C for 45 min.
36|
Transfer the supernatant into a new 1.5-ml tube. Transfer 100 ml into a 96-well plate and repeat the GFP fluorescent measurement as outlined in Step 11. Calculate the detergent solubilization efficiency by comparing to the GFP fluorescence measured in Step 35. In the example shown in Figure 5b , before ultracentrifugation, detergent solubilized membranes harbor a fusion in an aggregated and monodisperse state. In this example, all aggregation is removed by ultracentrifugation. This indicates that nondetergent solubilized fusion is protein in an aggregated state, rather than nonaggregated protein in detergent-resistant membranes (monodisperse peaks were equivalent before and after ultracentrifugation). However, because aggregation is still evident in many detergent-solubilized samples after ultracentrifugation 6 (e.g, Fig. 5c ), these aggregates are often solubilized with detergent to varying degrees. For this reason, the solubilization efficiency estimate is an unreliable indicator to decide the detergent for purification, and as such, samples should be analyzed by FSEC (see Steps 37-38) and, if possible, also for activity. 38| Set the 96-well parameters in the plate reader to read wells row-by-row. To improve the signal-to-noise ratio, measure the GFP fluorescence emission at 512 nm by excitation at 470 nm (this wavelength is used instead of 488 nm, as it produces a lower background fluorescent signal 6 ). Plot the GFP fluorescence in each well against the fraction number (Fig. 5c) . Alternatively, as originally outlined by Kawate and Gouaux 4 , the fluorescence can be measured with higher sensitivity using an in-line detector e.g., with a Prominence HPLC (Shimadzu). ? TROUBLESHOOTING Purification of membrane protein-GFP fusions TIMING 2 d 39| Dilute the membrane suspension isolated from 10-15 l of culture into a 500-ml beaker at a final protein concentration of 3 mg ml À1 using EB. Add the detergent powder, as outlined in Steps 33-38, that produced the most homogeneous sample. Incubate mixture at 4 1C for 1 h with mild agitation (Fig. 6) . Note that the EB composition should be considered a starting point only, and inhibitors should be added at this point if necessary.
40| Pellet the unsolubilized material by centrifugation at 100,000g at 4 1C for 45 min. Transfer supernatant into an appropriately sized glass beaker. Transfer 100 ml of the detergent-solubilized membranes to a 96-well plate and measure GFP fluorescence as outlined in Step 11. Calculate the amount of the GFP fusion as detailed in Box 2.
41| Use 1 ml of Ni-NTA resin (2 ml of 50% slurry) per 1 mg of GFP fusion to be purified (Step 40), and equilibrate with five column volumes of EB. m CRITICAL STEP As the His tag is C-terminal to GFP, the amount of GFP that will bind as a fusion is calculated at this step rather than the amount of membrane protein. Although the level of resin used is much higher than for soluble proteins, we have empirically found that this amount is necessary to ensure good binding efficiency. 45| Add 1 M imidazole to EB to a final concentration of 250 mM and elute the protein from column using 2-3 column volumes.
46| Transfer 100 ml of the eluate into a 96-well plate and measure GFP fluorescence as outlined in Step 11. Determine the amount of GFP fusion (Box 2). The amount of GFP-fusion in the eluate should be determined by measuring GFP fluorescence as the BCA assay measures total protein content (including contamination).
Removal of GFP-8His tag from the membrane protein-GFP fusion TIMING 16 h 47| Add to the GFP fusion an equal amount of His-tagged TEV protease as calculated in Step 46. Transfer into dialysis tubing and dialyze overnight at 4 1C against B3 l of DB. In this protocol, the TEV protease constructed by Doudna and co-workers was used 16 , which describes how to overexpress and isolate His-tagged TEV protease. Conveniently, GFP and TEV protease have approximately the same M r , which means a quick calculation for the amount of GFP-fusion is a molar equivalent of TEV protease. For commonly used detergents, such as DDM, equimolar amounts of TEV protease is typically sufficient for a complete overnight digest at 4 1C (ref.
2). The DB chosen here is only a starting point.
48| Optional: After overnight dialysis, add 10 ml of digest to 10 ml SB and process as described in Steps 17-19. Analyze the TEV digest reaction for completeness by in-gel fluorescence. Usual cleavage under these conditions is 498% complete. Note that we do not add any additional DTT to the TEV protease from that already contained in its storage buffer. 50-ml Falcon tube. After collecting the flowthrough, the bound material (GFP-8His, His-tagged TEV protease and contaminating proteins) can be eluted using buffer containing 250 mM imidazole. Elution can be analyzed by SDS-PAGE to confirm that the cleaved membrane protein did not inadvertently bind to the His-Trap column.
51| Concentrate the flowthrough from
Step 50 using a centrifugal concentrator to 0.5 ml. Calculate the amount of protein using the BCA assay and lower to 20 mg ml À1 if necessary. Inject 0.5 ml onto a Superdex 200 10/300 column pre-equilibrated with buffer used for dialysis at a flow rate of 0.5 ml min À1 . Alternatively, if crystallization screening is the final step, inject only half of the sample onto the size-exclusion column, as it has been found that lipid removal by SEC can influence the quality of the membrane protein crystals 23 . Another strategy shown to be successful is to equilibrate the column in buffer that also contain lipids 24 . To use the sample without SEC, remove imidazole by re-diluting and concentrating sample several times.
52|
Collect 0.5 ml-fractions. Analyze the UV-trace and collect and pool the membrane protein peak.
53| Analyze the eluate (membrane protein-GFP fusion), the flowthrough (membrane protein before SEC) and the protein peak (membrane protein after SEC) by SDS-PAGE (Fig. 7a) . 
ANTICIPATED RESULTS
To date, we have cloned 110 eukaryotic transport proteins into a GFP-fusion vector: 30 from yeast and 80 from higher eukaryotic organisms. After obtaining colonies (Steps 2 and 3), we tested the expression (Steps 4-11) of two colonies from each transformation. In 90% of the cases, whole-cell GFP counts in both colonies were similar. In cases where whole-cell GFP fluorescence over background was low (o5,000 relative fluorescence units (RFU)), correct clones could be confirmed by PCR and/or DNA sequencing. Thus, error-free clones should be obtained quickly by homologous recombination. Analyzing the overexpression levels for these clones (Box 2), we find that only 25% of mammalian membrane proteins, compared with 75% of yeast membrane proteins, were produced 41 mg l À1 (ref. 6) . These data emphasize the importance of initially screening the overexpression potential of many membrane proteins. Typical in-gel fluorescence of isolated crude membranes (Steps 12-19) for 20 targets is illustrated in Figure 3a . As shown in Figure 3b , 10 ml whole-cell screening provides reliable estimates for large-scale production up to 50-l fermentations. Importantly, there is a good correlation (R 2 ¼ 0.8) between whole-cell and membrane-integrated expression, Figure 3c ,d. This correlation means that overexpression culture conditions can be confidently optimized by whole-cell GFP fluorescence measurements. Modest improvement (typically 30%) could be obtained for a third of transport proteins tested by adding DMSO or His to the culture medium (Steps 20-23) 6 .
So far, analysis of membrane protein localization by confocal microscopy (Steps 24-26) is consistent with all previously reported functional localization data for membrane protein-GFP fusions 6 . Overall, 70% of membrane proteins tested were targeted to the correct organelle. Typical localization patterns are shown in Figure 4 (for further examples, see core reference article 6 ). We found no correlation between overexpression levels and mistargeting.
Detergent screening and FSEC analysis (Steps 33-38) has been carried out for 33 eukaryotic transporters: 15 from S. cerevisiae and 18 from Rattus norvegicus, Mus musculus or Homo sapiens. Our criterion for monodispersity is that a protein peak is symmetric and is equal to or larger than any 'free GFP' or aggegration peak(s). A typical detergent screen for a yeast membrane protein-GFP fusion is shown in Figure 5c . In this example, the detergents DDM, DM and LDAO produce a monodisperse peak, whereas Fos-choline 12 and C 12 E 9 detergents do not (for further examples see refs. 4, 6) . We have found no correlation between the efficiency of the detergent to extract the fusion protein and the quality of the FSEC traces 6 . We attribute this poor correlation to the ability of detergents to solubilize fusion protein that has aggregated (Fig. 5b) . Eleven of fifteen yeast and seventeen of eighteen mammalian transporters tested were monodisperse in at least one detergent. Nine of these yeast membrane proteins and all mammalian membrane proteins produced monodisperse profiles after purification by IMAC (Steps 39-46) (results not shown). After GFP-8His cleavage by His-tagged TEV protease and reverse IMAC (Steps 47-50), all yeast proteins and 15 of the 17 mammalian transporters were monodisperse as untagged proteins (2 mammalian transporters aggregated after the removal of the GFP-8His tag). Overall, 60% of the yeast and 85% of the mammalian transporters that expressed 41 mg l À1 could be purified as homogeneous samples (Steps 51-53) (see Fig. 6f , and core reference article ref. 6 ). So far, we have monitored the transport activity for four mammalian transporters. Activity is consistent with the activity of these proteins recorded either in vivo or after reconstitution into lipids (Sonada, Y. et al., manuscript in preparation). Specific binding of a inhibitor to one of these proteins in detergent solution is illustrated in Figure 7b . An example data-sheet encompassing most steps outlined in this protocol is shown in Table 1 . We have found this information important for troubleshooting and for maintaining reproducibility in a large-group setting. 
